Skip to main content
Home
FULL MENU Close Menu
Home
Home

Sharon Worcester

Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.

News

Study finds no link between platelet count, surgery bleed risk in cirrhosis

Author:
Sharon Worcester
Publish date: August 5, 2020

Logistic regression analysis showed no significant association between platelet count and major bleeding events.

  • Read More

News

Higher death rate seen in cancer patients with nosocomial COVID-19

Author:
Sharon Worcester
Publish date: July 30, 2020

All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.

  • Read More

News

Large cohort study: Bevacizumab safe, effective for severe HHT bleeds

Author:
Sharon Worcester
Publish date: July 29, 2020

Bevacizumab was effective for severe HHT-related epistaxis and GI bleeds, leading to "significant and striking improvements" on a variety of...

  • Read More

News

CCC19, other registries help define COVID/cancer landscape

Author:
Sharon Worcester
Publish date: July 27, 2020

New data from CCC19 show an increased risk of death from COVID-19 among non-Hispanic black cancer patients and patients with hematologic...

  • Read More

News

SPK-8011 AAV-mediated hemophilia A therapy shows stability, durability

Author:
Sharon Worcester
Publish date: July 27, 2020

The findings demonstrate preliminary stability of FVIII expression at follow-up between 2 and 3.3 years....

  • Read More

News

Liver biopsies show persistent FVIII after gene therapy for hemophilia A

Author:
Sharon Worcester
Publish date: July 16, 2020

“This was very exciting to see ... [n]ot only were we able to detect vector genomes more than 2 years post-dose, there seems to be quite a bit of...

  • Read More

News

Analysis of early onset cancers suggests need for genetic testing

Author:
Sharon Worcester
Publish date: July 14, 2020

The prevalence of germline mutations was significantly higher in patients with early onset cancers than in those with young adult cancers.

  • Read More

News

AI markers can predict progression, survival in prostate cancer

Author:
Sharon Worcester
Publish date: July 13, 2020

Artificial intelligence–based Gleason scores correlated with pathologists’ Gleason scores.

  • Read More

News

Lipophilic statins linked to lower mortality in ovarian cancer

Author:
Sharon Worcester
Publish date: July 6, 2020

Lipophilic statin use was associated with a 43% reduction in mortality.

  • Read More

News

Novel SERD, LSZ102, shows promise for pretreated ER+ breast cancer

Author:
Sharon Worcester
Publish date: June 30, 2020

LSZ102 was relatively well tolerated as a single agent and in combination with ribociclib and alperisib.

  • Read More

News

Tumor markers are ‘valuable’ for relapse detection in rare CNS tumors

Author:
Sharon Worcester
Publish date: June 26, 2020

Among evaluable patients, 92% of relapses were detectable by tumor markers.

  • Read More

News

Sequential chemoradiation improves DFS in early-stage cervical cancer

Author:
Sharon Worcester
Publish date: June 22, 2020

The 3-year disease-free survival rate was significantly higher among patients who received sequential chemoradiation than among patients who...

  • Read More

News

Immunotherapy combo improves ORR, PFS in PD-L1+ NSCLC

Author:
Sharon Worcester
Publish date: June 22, 2020

Adding tiragolumab to atezolizumab led to “clinically meaningful” improvements in patients with PD-L1–positive non–small cell lung cancer.

  • Read More

News

No OS benefit with gefitinib vs. chemo for EGFR+ NSCLC

Author:
Sharon Worcester
Publish date: June 10, 2020

Adjuvant gefitinib improved disease-free survival, but not overall survival, when compared with standard chemotherapy.

  • Read More

News

Addressing racism, bias in the American maternal mortality crisis

Author:
Sharon Worcester
Publish date: June 2, 2020

“I think the most important thing you can do is really consider a patient a partner in the care you give them.”

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close